Shares of Adial Pharmaceuticals, Inc. (ADIL) are up 81% on Wednesday following the release of a peer-reviewed article on AD04 which is a low-dose ondansetron, the Company's primary investigational drug for Alcohol Use Disorder or AUD treatment.
Adial Pharmaceuticals promising update on alcohol disorder drug invezz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from invezz.com Daily Mail and Mail on Sunday newspapers.
Adial Pharmaceuticals, Inc. announced the publication of a peer-reviewed article highlighting the promising clinical results, strong safety profile and high compliance among patients administered AD04.
A new study showed how taking alcohol use disorder medication following an alcohol-related hospitalization discharge was linked to a reduction in return to hospital in 30 days.